Lucas Ward
Stock Analyst at Ascendiant Capital
(0)
# 5001
Out of 5,218 analysts
15
Total ratings
23.08%
Success rate
-38.79%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Aclarion | Maintains: Buy | 2 2 | 0.1 | 1200% | 3 | Nov 27, 2024 | |
LiqTech Intl | Maintains: Buy | 6 4 | 1.9 | 68.42% | 3 | Nov 25, 2024 | |
Vivos Therapeutics | Reiterates: Buy | 7 7 | 4.64 | 42.24% | 2 | Nov 20, 2024 | |
Heart Test Laborator... | Reiterates: Buy | 15 15 | 3.77 | 297.88% | 1 | Sep 23, 2024 | |
Cyclo Therapeutics | Maintains: Buy | 3 1 | 0.57 | 66.67% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 338 270 | 1.46 | 18393.15% | 2 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 1.38 | 1986.96% | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2160 | n/a | n/a | 1 | Mar 6, 2023 |